在人体内随着时间的推移对杜拉根原基质基质的组织病理学分析
Takuma Maeda1,2, Kaima Suzuki3, Peyton L Nisson4,5
1Department of Cerebrovascular Surgery, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan. maeda412@saitama-med.ac.jp.
Scientific reports
|April 1, 2025
概括
在植入后34天内,DuraGen,一种原基质,被体内自身的原蛋白取代,用于 dura再生. 这项研究详细介绍了DuraGen在人类患者中移植愈合的组织病理时间表.
科学领域:
- 神经外科 神经外科
- 生物材料科学 生物材料科学
- 组织病理学 组织病理学
背景情况:
- 杜拉基因 (DuraGen) 是一种来自牛的阿基里斯肌的I型原基质,用于杜拉再生.
- 人类内皮膜再生和DuraGen移植再吸收的时间表尚未确定.
研究的目的:
- 评估DuraGen植入物在人类患者中的组织病理学特征和愈合时间表.
- 为了确定DuraGen再吸收和被内源组织替换所需的时间.
主要方法:
- 在去压缩性脑膜切除术后,预期招募28名接受DuraGen治疗的患者.
- 在早期 (0-20天),中期 (21-30天) 和晚期 (>30天) 的时间点,对解剖DuraGen和周围组织进行了组织病理学分析.
- 对不同时间组的基线特征和组织病理学发现进行比较.
主要成果:
- 组织病理学分析显示,随着时间的推移,植入的原基质,红细胞和纤维素的减少.
- 随着移植的愈合,观察到纤维细胞和内源性原沉积的增加.
- 受体操作特征分析确定34天为显著内源原体存在的截止期,表明DuraGen替代.
结论:
- 在植入后34天,DuraGen被纤维细胞衍生的内源原蛋白所取代.
- 这项研究支持DuraGen作为基于观察到的组织病理变化的持续修复的可靠替代品.
- 需要进一步验证,但研究结果提供了对DuraGen移植集成和愈合动态的洞察.
相关概念视频
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...